{
  "primary": "YAP1",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "Direct interaction between ATXN3 and YAP1 was confirmed by co-immunoprecipitation (Co-IP) and in vitro pulldown assays, where ATXN3 deubiquitinates and stabilizes YAP1.",
  "functions": [
    {
      "function": "YAP1 Protein Stability & Hippo Pathway Signaling",
      "arrow": "activates",
      "cellular_process": "ATXN3 acts as a deubiquitinase for YAP1, the primary effector of the Hippo tumor suppressor pathway. ATXN3 removes K48-linked polyubiquitin chains from YAP1, protecting it from proteasomal degradation.",
      "effect_description": "This interaction stabilizes YAP1 protein, leading to its accumulation and increased transcriptional activity of its target genes, which promotes cell proliferation, invasion, and stem-like properties, particularly in cancer.",
      "biological_consequence": [
        "ATXN3 deubiquitinates YAP1 → YAP1 protein is stabilized → Increased nuclear YAP1 → Enhanced transcription of YAP target genes (CTGF, ANKRD1, CYR61) → Promotion of cell proliferation and invasion"
      ],
      "specific_effects": [
        "ATXN3 interacts with, deubiquitinates, and stabilizes YAP1 in a deubiquitylation activity-dependent manner.",
        "The Josephin domain of ATXN3 interacts with the WW domain of YAP1.",
        "Depletion of ATXN3 decreases YAP protein levels and the expression of YAP/TEAD target genes."
      ],
      "evidence": [
        {
          "paper_title": "ATXN3 promotes prostate cancer progression by stabilizing YAP",
          "year": 2023,
          "pmid": "37349820"
        }
      ],
      "_context": {
        "type": "direct",
        "query_protein": null,
        "chain": null
      },
      "interaction_effect": "activates",
      "direction": "main_to_primary",
      "interaction_direction": "main_to_primary",
      "pathway": {
        "name": "Hippo Signaling Pathway",
        "canonical_name": "Hippo Signaling",
        "ontology_id": "hsa04390",
        "ontology_source": "KEGG",
        "confidence": 0.8
      },
      "pmids": [
        "37349820"
      ],
      "function_effect": "activation"
    }
  ],
  "arrow": "activates",
  "direction": "main_to_primary",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "mechanism": "ATXN3 acts as a deubiquitinase for YAP1, the primary effector of the Hippo tumor suppressor pathway. ATXN3 removes K48-linked polyubiquitin chains from YAP1, protecting it from proteasomal degradation.",
  "effect": "This interaction stabilizes YAP1 protein, leading to its accumulation and increased transcriptional activity of its target genes, which promotes cell proliferation, invasion, and stem-like properties, particularly in cancer.",
  "summary": "ATXN3 activates YAP1 to modulate yap1 protein stability & hippo pathway signaling, ultimately affecting promotion of cell proliferation and invasion.",
  "evidence": [
    {
      "paper_title": "ATXN3 promotes prostate cancer progression by stabilizing YAP",
      "year": 2023
    }
  ],
  "pathways": [
    {
      "name": "Hippo Signaling Pathway",
      "canonical_name": "Hippo Signaling",
      "ontology_id": "hsa04390",
      "ontology_source": "KEGG",
      "confidence": 0.8
    }
  ],
  "interaction_effect": "activation",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 0
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 --activates--> YAP1:",
  "protein_a": "ATXN3",
  "protein_b": "YAP1",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-12-07T22:39:21.487889Z",
  "last_updated": "2025-12-07T22:39:21.487889Z"
}